Zeo ScientifiX Q2 Revenue Jumps 125% to $2.58M, Net Loss Narrows Significantly
Summary
Zeo ScientifiX reported Q2 2026 revenue of $2.58 million, a 124.6% increase year-over-year, while significantly narrowing its net loss by 89.6% to ($145K), resulting in an EPS of ($0.02). This strong financial performance follows a series of positive operational updates, including new strategic partnerships and surpassing $1 million in monthly sales. For a micro-cap company, this substantial revenue growth and progress towards profitability are highly material, validating recent business development and commercialization efforts. The company is also advancing its clinical study and product pipeline.
At the time of this announcement, ZEOX was trading at $1.70 on OTC in the Life Sciences sector, with a market capitalization of approximately $13.2M. The 52-week trading range was $1.20 to $2.99. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.